The HealthRise Program selects projects and finances their implementation, seeking to improve access to diagnosis and treatment of cardiovascular diseases (CVD) and diabetes in poor communities. Held simultaneously in India, South Africa and the United States, the program selects projects and finances their implementation, contributing to the World Health Organization (WHO) goal of reducing premature mortality associated with these diseases by 25% by 2025.
This initiative is the result of a partnership between the Syrian-Lebanese Institute of Teaching and Research (IEP/HSL), the consultancy Abt Associates and the Medtronic Foundation. Interested parties must submit their proposals by July 8, according to the public notice.
Learn more and participate: http://bit.ly/1Pg3tlo